Comparison of 11C-methionine PET and 18F-FDG PET in patients with primary central nervous system lymphoma

Molecular Imaging and Biology

Volumn 13, Issue 6, 2011, Pages 1284-1289

  Kawase, Yoshiro ^a   Yamamoto, Yuka ^a   Kameyama, Reiko ^a   Kawai, Nobuyuki ^b   Kudomi, Nobuyuki ^b   Nishiyama, Yoshihiro ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

11C methionine; 18F FDG; CNS lymphoma; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; METHIONINE C 11; CARBON; DIAGNOSTIC AGENT; METHIONINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG UPTAKE; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; CENTRAL NERVOUS SYSTEM TUMOR; COMPARATIVE STUDY; LYMPHOMA; MIDDLE AGED; RADIOGRAPHY; SCINTISCANNING; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; CARBON RADIOISOTOPES; CENTRAL NERVOUS SYSTEM NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LINEAR MODELS; LYMPHOMA; MALE; METHIONINE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY;

EID: 84855664884     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-010-0447-1     Document Type: Article

References (21)

1. Corn BW, Marcus SM, Tophan A, Hauck W, Curran WJ Jr (1997) Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000? Cancer 79:2409-2413 (Pubitemid 27251026)
2. Behin A, Hoang-Xuan K, Caroentier AF, Delattre J-Y (2003) Primary brain tumours in adults. Lancet 361:323-331 (Pubitemid 36126198)
3. Basso U, Brandes AA (2002) Diagnostic advances and new trends for treatment of primary central nervous system lymphoma. Eur J Cancer 38:1298-1312 (Pubitemid 34686839)
4. Abrey LE, Yahalom J, DeAngelis LM (2000) Treatment for primary CNS lymphoma: The next step. J Clin Oncol 18:3144-3150
5. Rosenfeld SS, Hoffman JM, Coleman RE, Glantz MJ, Hanson MW, Schold SC (1992) Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxyglucose positron emission tomography. J Nucl Med 33:532-536
6. Di Chiro G, DeLaPaz RL, Brooks RA et al (1982) Glucose utilization of cerebral gliomas measured by [18]F fluorodeoxyglucose and positron emission tomography. Neurology 32:1323-1329 (Pubitemid 13218489)
7. Alavi JB, Alavi A, Chawluk J et al (1988) Positron emission tomography in patients with glioma. A predictor of prognosis. Cancer 62:1074-1078
8. Hoffman JM, Waskin HA, Schifter T et al (1993) FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. J Nucl Med 34:567-575 (Pubitemid 23115656)
9. Roelcke U, Leenders KL (1999) Positron emission tomography in patients with primary CNS lymphomas. J Neuro Oncol 43:231-236 (Pubitemid 29488380)
10. Palmedo H, Urbach H, Bender H et al (2006) FDG-PET in immunocompetent patients with primary central nervous system lymphoma: Correlation with MRI and clinical follow-up. Eur J Nucl Med Mol Imaging 33:164-168 (Pubitemid 43152883)
11. Nishiyama Y, Yamamoto Y, Monden T et al (2007) Diagnostic value of kinetic analysis using dynamic FDG PET in immunocompetent patients with primary CNS lymphoma. Eur J Nucl Med Mol Imaging 34:78-86 (Pubitemid 44885557)
12. Kimura N, Yamamoto Y, Kameyama R, Hatakeyama T, Kawai N, Nishiyama Y (2009) Diagnostic value of kinetic analysis using dynamic FDG PET in patients with malignant primary brain tumor. Nucl Med Commun 30:602-609
13. Ogawa T, Shishido F, Kanno I et al (1993) Cerebral glioma: Evaluation with methionine PET. Radiology 186:45-53 (Pubitemid 23005465)
14. Sasaki M, Kuwabara Y, Yoshida T et al (1998) A comparative study of thallium-201 SPET. Carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours. Eur J Nucl Med 25:1261-1269 (Pubitemid 28446052)
15. Yamamoto Y, Nishiyama Y, Kimura N et al (2008) 11C-Acetate PET in the evaluation of brain glioma: Comparison with 11C-methionine and 18F-FDG-PET. Mol Imaging Biol 10:281-287
16. Ogawa T, Kanno I, Hatazawa J et al (1994) Methionine PET for followup of radiation therapy of primary lymphoma of the brain. Radio- Graphics 14:101-110
17. Ishiwata K, Ido T, Vaalburg W (1988) Increased amounts of Denantiomer dependent on alkaline concentration in the synthesis of L- [methyl-11C] methionine. Appl Radiat Isot 39:311-314
18. Toorongian SA, Mulholland GK, Jewett DM, Bachelor MA, Kilbourn MR (1990) Routine production of 2-deoxy-2-[18F] fluoro-D-glucose by direct nucleophilic exchange on a quaternary 4-aminopyridinium resin. Nucl Med Biol 17:273-279 (Pubitemid 20110114)
19. Liu RS, Chang CP, Chu LS et al (2006) PET imaging of brain astrocytoma with 1-11C-acetate. Eur J Nucl Med Mol Imaging 33:420-427
20. Hoskin PJ (2003) PET in lymphoma: What are the oncologist's needs? Eur J Nucl Med Mol Imaging 30:S37-S41 (Pubitemid 36735761)
21. Tanaka Y, Nariai T, Momose T et al (2009) Glioma surgery using a multimodality navigation system with integrated metabolic images. J Neurosurg 110:163-172